In re Caremark International Inc. Derivative Litigation
Legal case and corporate law precedent / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about In re Caremark International Inc. Derivative Litigation?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
In re Caremark International Inc. Derivative Litigation, 698 A.2d 959 (Del. Ch. 1996),[1] is a civil action that came before the Delaware Court of Chancery. It is an important case in United States corporate law and discusses a director's duty of care in the oversight context. It raised the question regarding compliance, "what is the board's responsibility with respect to the organization and monitoring of the enterprise to assure that the corporation functions within the law to achieve its purposes?" Chancellor Allen wrote the opinion.
Quick Facts In re Caremark International Inc. Derivative Litigation, Court ...
In re Caremark International Inc. Derivative Litigation | |
---|---|
Court | Delaware Court of Chancery |
Full case name | In re Caremark International Inc. Derivative Litigation |
Decided | September 25, 1996 |
Citation(s) | 698 A.2d 959 (Del. Ch. 1996) |
Court membership | |
Judge(s) sitting | Chancellor William T. Allen |
Keywords | |
Close
Wikisource has original text related to this article: